Vladimir Vexler - Jan 20, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Chief Scientific Officer
Signature: /s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Stock symbol: CHRS
Transactions as of: Jan 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/24/2023, 03:47 PM
Previous filing: Jan 12, 2023
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHRS	Common Stock	Award	$0	+40K	+43.8%	$0.00	131K	Jan 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Content

Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.